Literature DB >> 15292687

Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients.

B Mazul-Sunko1, N Zarković, N Vrkić, N Antoljak, M Bekavac Beslin, V Nikolić Heitzler, M Siranović, A Krizmanić-Dekanić, R Klinger.   

Abstract

INTRODUCTION: N-terminal prohormone of atrial natriuretic peptide ((proANP(1-98)) has been extensively analyzed in patients with chronic renal failure. It has been found to be closely related to the renal function and to interdialytic hydration status. The clinical relevance of proANP(1-98) and cystatin C, a novel marker of glomerular filtration, has not been investigated in the subgroup of critically ill septic patients with no history of chronic renal impairment.
METHODS: We measured plasma level ofproANP(1-98) and cystatin C in 29 critically ill septic patients on admittance to the surgical intensive care unit and correlated it with the occurrence of acute renal failure.
RESULTS: The proANP(1-98) plasma level was significantly higher in the group of patients who developed renal failure (12,722 +/- 12,421 vs. 2,801+/- 2,023 fmol/ml, p < 0.05). Multiple regression analysis shows that proANP(1-98) on the first day in the intensive care unit has a superior predictive value for the occurrence of renal failure to diuresis, calculated creatinine clearance or cystatin C (r = 0.42, p < 0.039). proANP(1-98) is also higher in non-survivors (9,303.8 +/- 11,053 vs. 2,448.5 +/- 1,803 fmol/ml, p < 0.018).
CONCLUSION: proANP(1-98) is possibly a better predictor of acute renal failure to calculated creatinine clearance or diuresis among critically ill septic patients. Cystatin C was not correlated with occurrence of acute renal failure in this subgroup of patients. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292687     DOI: 10.1159/000078638

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  5 in total

1.  The incidence and clinical features of acute kidney injury secondary to ureteral calculi.

Authors:  Si-Jun Wang; Xiao-Nan Mu; Long-Yang Zhang; Qing-Yong Liu; Xun-Bo Jin
Journal:  Urol Res       Date:  2011-08-19

2.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

3.  Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

Authors:  Annick A N M Royakkers; Johanna C Korevaar; Jeroen D E van Suijlen; Lieuwe S Hofstra; Michael A Kuiper; Peter E Spronk; Marcus J Schultz; Catherine S C Bouman
Journal:  Intensive Care Med       Date:  2010-12-10       Impact factor: 17.440

4.  Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine.

Authors:  Mohammad Mahdi Sagheb; Soha Namazi; Bita Geramizadeh; Amin Karimzadeh; Mohammad Bagher Oghazian; Iman Karimzadeh
Journal:  Nephrourol Mon       Date:  2014-03-01

5.  Biomarkers in Acute Kidney Injury.

Authors:  Jean-François Naud; Martine Leblanc
Journal:  Biomark Insights       Date:  2008-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.